Medtronic (NYSE:MDT) announced today that it exercised its option to acquire coronary artery disease (CAD) tech developer ...
Medtronic expands cath lab tools by acquiring CathWorks for $585 million, enhancing its interventional cardiology portfolio with AI technology.
The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results